Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingliang Chen

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Advanced Healthcare Materials|May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug CarrierBingliang Chen, Liying Wang, Ruihui Xie, et al.
Journal of Translational Medicine|April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerRuilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Translational Oncology|September 2, 2022
Comprehensive analysis to identify the RP11-478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinomaKai Zeng, Guoda Song, Bingliang Chen, et al.
Disease Markers|October 17, 2022
Identification of Calcium Channel-Related Gene P2RX2 for Prognosis and Immune Infiltration in Prostate CancerQinyu Li, Bili Wu, Motuma Daba, et al.
Translational Andrology and Urology|August 12, 2022
Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysisBingliang Chen, Bingyan Zhou, Guoda Song, et al.
Cancer Letters|April 5, 2022
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myelomaKeke Fei, Haiqing Ni, Mengjia Zhu, et al.
Frontiers in Medicine|June 14, 2021
Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-AnalysisGuoda Song, Min Wang, Bingliang Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer ProgressionShirong Peng, Weilong Lin, Zean Li, et al.
Phytotherapy Research : PTR|May 9, 2025
Identification of Sinigrin as Active Compound of Rape Pollen for Treating Benign Prostatic Hyperplasia Through PI3K/AKT/mTOR AxisBingliang Chen, Yingchao Wang, Guoda Song, et al.
Mabs|August 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefitJie Wang, Keke Fei, Hua Jing, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Advanced Healthcare Materials|May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug CarrierBingliang Chen, Liying Wang, Ruihui Xie, et al.
Journal of Translational Medicine|April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerRuilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Translational Oncology|September 2, 2022
Comprehensive analysis to identify the RP11-478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinomaKai Zeng, Guoda Song, Bingliang Chen, et al.
Disease Markers|October 17, 2022
Identification of Calcium Channel-Related Gene P2RX2 for Prognosis and Immune Infiltration in Prostate CancerQinyu Li, Bili Wu, Motuma Daba, et al.
Translational Andrology and Urology|August 12, 2022
Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysisBingliang Chen, Bingyan Zhou, Guoda Song, et al.
Cancer Letters|April 5, 2022
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myelomaKeke Fei, Haiqing Ni, Mengjia Zhu, et al.
Frontiers in Medicine|June 14, 2021
Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-AnalysisGuoda Song, Min Wang, Bingliang Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer ProgressionShirong Peng, Weilong Lin, Zean Li, et al.
Phytotherapy Research : PTR|May 9, 2025
Identification of Sinigrin as Active Compound of Rape Pollen for Treating Benign Prostatic Hyperplasia Through PI3K/AKT/mTOR AxisBingliang Chen, Yingchao Wang, Guoda Song, et al.
Mabs|August 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefitJie Wang, Keke Fei, Hua Jing, et al.
Pageof 5